- Home
- NRIM vs BVS Comparison
NRIM vs BVS Comparison
Compare NRIM & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NRIM
- BVS
- Stock Information
- Founded
- NRIM 1990
- BVS 2011
- Country
- NRIM United States
- BVS United States
- Employees
- NRIM N/A
- BVS N/A
- Industry
- NRIM Savings Institutions
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- NRIM Finance
- BVS Health Care
- Exchange
- NRIM Nasdaq
- BVS Nasdaq
- Market Cap
- NRIM 514.9M
- BVS 432.7M
- IPO Year
- NRIM N/A
- BVS 2021
- Fundamental
- Price
- NRIM $92.96
- BVS $7.54
- Analyst Decision
- NRIM
- BVS Strong Buy
- Analyst Count
- NRIM 0
- BVS 5
- Target Price
- NRIM N/A
- BVS $14.40
- AVG Volume (30 Days)
- NRIM 45.4K
- BVS 523.1K
- Earning Date
- NRIM 07-23-2025
- BVS 08-06-2025
- Dividend Yield
- NRIM 2.92%
- BVS N/A
- EPS Growth
- NRIM 38.28
- BVS N/A
- EPS
- NRIM 7.99
- BVS 0.03
- Revenue
- NRIM $175,041,000.00
- BVS $564,142,000.00
- Revenue This Year
- NRIM $11.28
- BVS N/A
- Revenue Next Year
- NRIM $6.67
- BVS $6.26
- P/E Ratio
- NRIM $10.96
- BVS $260.36
- Revenue Growth
- NRIM 28.34
- BVS 5.08
- 52 Week Low
- NRIM $63.64
- BVS $5.81
- 52 Week High
- NRIM $100.21
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- NRIM 51.93
- BVS 53.68
- Support Level
- NRIM $85.73
- BVS $7.03
- Resistance Level
- NRIM $88.48
- BVS $7.48
- Average True Range (ATR)
- NRIM 1.65
- BVS 0.40
- MACD
- NRIM 0.65
- BVS 0.02
- Stochastic Oscillator
- NRIM 90.85
- BVS 73.45
About NRIM Northrim BanCorp Inc
Northrim BanCorp Inc is a bank holding company. The Company operates in three reportable segments: Community Banking, Home Mortgage Lending, and Specialty Finance. It generates maximum revenue from the Community Banking segment which offers loan and deposit products to business and consumer customers in its market areas and operates nearly 20 branches throughout Alaska.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.